Amgen (AMGN) Change in Inventory (2009 - 2026)

Amgen (AMGN) has reported Change in Inventory for 18 consecutive years, with -$18.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Inventory rose 93.75% year-over-year to -$18.0 million; the TTM figure through Mar 2026 stood at -$616.0 million (up 69.41% YoY), while the FY2025 annual figure was -$886.0 million, up 65.01% from the prior year.
• Change in Inventory came in at -$18.0 million for Q1 2026 at Amgen, up from -$119.0 million in the prior quarter.
• The five-year high for Change in Inventory was $241.0 million in Q3 2022, with the low at -$806.0 million in Q1 2024.
• Average Change in Inventory over 5 years is -$187.4 million, with a median of -$119.0 million recorded in 2025.
• Across the five-year window, Change in Inventory surged 402.08% in 2022 and tumbled 2306.67% in 2024, its largest moves.
• Year by year, Change in Inventory stood at $91.0 million in 2022, then tumbled by 729.67% to -$573.0 million in 2023, then soared by 43.63% to -$323.0 million in 2024, then jumped by 63.16% to -$119.0 million in 2025, then soared by 84.87% to -$18.0 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$18.0 million, -$119.0 million, and -$240.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.